Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Glaxo Wellcome UK Limited, trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS
Eumovate Cream.
| Pharmaceutical Form |
|---|
|
Water miscible cream. |
0.05% w/w clobetasone butyrate.
Excipients with known effect:
Cetostearyl alcohol
Chlorocresol
This product contains paraffin, see section 4.4.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Clobetasone |
Clobetasone is a topical corticosteroids. Clobetasone has little effect on hypothalamo-pituitary-adrenal function. Clobetasone is less potent than other available corticosteroid preparations and has been shown not to suppress the hypothalamo-pituitary-adrenal axis in patients treated for psoriasis or eczema. |
| List of Excipients |
|---|
|
Glycerol |
Internally lacquered aluminium tubes with latex band and wadless polypropylene cap.
30 and 100gm tubes are available (25gm pack is also registered).
Glaxo Wellcome UK Limited, trading as GlaxoSmithKline UK, 980 Great West Road, Brentford, Middlesex, TW8 9GS
PL 10949/0035
30 April 1999
| Drug | Countries | |
|---|---|---|
| EUMOVATE | Hong Kong, Ireland, Malta, New Zealand, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
